Spotlighting a regional first in emergency allergy care.
EURneffy, the first adrenaline nasal spray approved in the UAE for the emergency treatment of severe allergic reactions (anaphylaxis), has been authorized by the Emirates Drug Establishment. This marks a significant step forward, offering a needle-free alternative for one of the most critical moments in an allergic emergency.
Designed for rapid, easy use—even without medical training—this milestone reflects the kind of innovation reshaping emergency care across the region.
Emergency treatment of anaphylaxis made easier.
